Intero Biosystems wants drugmakers to test on mini human intestines, not animals | TechCrunch
作者 Kate Park
文章摘要
TechCrunch · 文章頁摘要Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

原站閱讀
全文請至原站閱讀。